A new strategy for isolating genes controlling dosage compensation in Drosophilausing a simple epigenetic mosaic eye phenotype

Autor: Mahalakshmi Prabhakaran, Richard L. Kelley
Rok vydání: 2010
Předmět:
Male
Physiology
Plant Science
0302 clinical medicine
Structural Biology
Drosophila Proteins
lcsh:QH301-705.5
X chromosome
Histone Acetyltransferases
Genetics
Regulation of gene expression
0303 health sciences
Dosage compensation
Agricultural and Biological Sciences(all)
Pigmentation
Nuclear Proteins
Drosophila melanogaster
General Agricultural and Biological Sciences
Drosophila Protein
Biotechnology
X Chromosome
Blotting
Western
Molecular Sequence Data
Biology
General Biochemistry
Genetics and Molecular Biology
Histone H4
03 medical and health sciences
Sex Factors
Dosage Compensation
Genetic
Research article
Animals
Immunoprecipitation
Epigenetics
Ocular Physiological Phenomena
Gene
Ecology
Evolution
Behavior and Systematics
DNA Primers
030304 developmental biology
Base Sequence
Biochemistry
Genetics and Molecular Biology(all)
Genetic Complementation Test
fungi
Sequence Analysis
DNA
Cell Biology
Blotting
Northern
biology.organism_classification
lcsh:Biology (General)
Gene Expression Regulation
Mutagenesis
030217 neurology & neurosurgery
Transcription Factors
Developmental Biology
Zdroj: BMC Biology
BMC Biology, Vol 8, Iss 1, p 80 (2010)
ISSN: 1741-7007
DOI: 10.1186/1741-7007-8-80
Popis: Background The Drosophila Male Specific Lethal (MSL) complex contains chromatin modifying enzymes and non-coding roX RNA. It paints the male X at hundreds of bands where it acetylates histone H4 at lysine 16. This epigenetic mark increases expression from the single male X chromosome approximately twofold above what gene-specific factors produce from each female X chromosome. This equalises X-linked gene expression between the sexes. Previous screens for components of dosage compensation relied on a distinctive male-specific lethal phenotype. Results Here, we report a new strategy relying upon an unusual male-specific mosaic eye pigmentation phenotype produced when the MSL complex acts upon autosomal roX1 transgenes. Screening the second chromosome identified at least five loci, two of which are previously described components of the MSL complex. We focused our analysis on the modifier alleles of MSL1 and MLE (for 'maleless'). The MSL1 lesions are not simple nulls, but rather alter the PEHE domain that recruits the MSL3 chromodomain and MOF ('males absent on first') histone acetyltransferase subunits to the complex. These mutants are compromised in their ability to recruit MSL3 and MOF, dosage compensate the X, and support long distance spreading from roX1 transgenes. Yet, paradoxically, they were isolated because they somehow increase MSL complex activity immediately around roX1 transgenes in combination with wild-type MSL1 subunits. Conclusions We propose that these diverse phenotypes arise from perturbations in assembly of MSL subunits onto nascent roX transcripts. This strategy is a promising alternative route for identifying previously unknown components of the dosage compensation pathway and novel alleles of known MSL proteins.
Databáze: OpenAIRE
Externí odkaz: